Inhibition of the renin-angiotensin system provides renoprotective effects for patients with type 2 diabetes mellitus

被引：0
|
作者：
机构：
来源：
Drugs & Therapy Perspectives | 2003年 / 19卷 / 1期
关键词：
Diabetic Nephropathy; Ramipril; Irbesartan; Urinary Albumin Excretion; Candesartan Cilexetil;
D O I：
10.2165/00042310-200319010-00006
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：18 / 21
页数：3
相关论文
共 50 条
  • [41] COUGH AND INHIBITION OF THE RENIN-ANGIOTENSIN SYSTEM
    KARLBERG, BE
    JOURNAL OF HYPERTENSION, 1993, 11 : S49 - S52
  • [42] IERACAT COHORT STUDY: EFFECTIVENESS OF INHIBITORS OF THE RENIN-ANGIOTENSIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND HYPERTENSION IN CATALONIA
    Morros, R.
    Vedia, C.
    Bonet, S.
    Pera, G.
    Torres, F.
    Fina, F.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 111 : 18 - 19
  • [43] THE RENIN-ANGIOTENSIN SYSTEM AND ITS INHIBITION
    CORVOL, P
    ELKIK, F
    THIBONNIER, M
    PLOUIN, PF
    MENARD, J
    NOUVELLE PRESSE MEDICALE, 1981, 10 (19): : 1525 - 1530
  • [44] The effect of inhibition of the renin-angiotensin system on the development of diabetes mellitus: A meta-analysis of randomized trials
    Andraws, R
    Brown, DL
    CIRCULATION, 2005, 112 (17) : U848 - U848
  • [45] Renin-angiotensin system inhibition prevents type 2 diabetes mellitus - Part 1. A meta-analysis of randomised clinical trials
    Scheen, AJ
    DIABETES & METABOLISM, 2004, 30 (06) : 487 - 496
  • [46] The renin-angiotensin system and diabetes: An update
    Ribeiro-Oliveira, Antonio, Jr.
    Nogueira, Anelise Impeliziere
    Pereira, Regina Maria
    Vilas Boas, Walkiria Wingester
    Souza dos Santos, Robson Augusto
    Simoes e Silva, Ana Cristina
    VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (04) : 787 - 803
  • [47] Renoprotection in type 2 diabetes: blockade of the renin-angiotensin system with angiotensin II receptor blockers
    Swift, PA
    MacGregor, GA
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2001, 2 (03) : 170 - 173
  • [48] Renoprotective effect of antihypertensive therapy: Calcium channel blokade versus renin-angiotensin system inhibition
    Uejima, Etsuko
    Fujisawa, Tomomi
    Matsuoka, Aya
    Okamoto, Yoshiaki
    Ogihara, Toshio
    Kurokawa, Nobuo
    JOURNAL OF HYPERTENSION, 2006, 24 : 246 - 246
  • [49] Safety of dapagliflozin in patients with type 2 diabetes mellitus and hypertension inadequately controlled by a renin-angiotensin system blocker with/without a second agent
    Mansield, T. A.
    Weber, M. A.
    List, J. F.
    Ptaszynska, A.
    DIABETOLOGIA, 2014, 57 : S9 - S9
  • [50] Prevention of type 2 diabetes by inhibition of the renin-angiotensin system: Meta-analysis of randomized clinical trials
    Scheen, AJ
    DIABETES, 2004, 53 : A85 - A85
12345